Improvement of Prostaglandin-Associated Periorbitopathy after Discontinuing Treatment.

Jose Manuel Abalo-Lojo Pedro Vázquez Ferreiro Maria Knight Asorey Aida Estévez Colmenero Francisco Gonzalez

Published in: Turkish journal of ophthalmology (2023)

Clinicians and patients should be aware of the side effects of topical PGA therapy on periorbital tissues, and that these side effects can partially regress after discontinuation of the medication.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
healthcare
gene expression
prognostic factors
peritoneal dialysis
palliative care
stem cells
adverse drug
smoking cessation